2025-11-10T09:12:50+00:00 2024-12-31 440160260 Forvis Mazars LLP 500 Ridgefield Court Asheville NC 28806 990 2024-01-01 471195624 Amity Medical Group Inc AMIT 7042084134 6010 WT Harris Blvd Charlotte NC 28215 Olivia Bentley Chief Executive Officer 7042084134 2025-11-10 true Amy Bibby P00445891 8282542254 2025-09-12 2024 2025-03-06 01:10:19Z Olivia Bentley 6010 WT Harris Blvd Charlotte NC 28215 28083110 false X www.amitymed.org X 2014 NC To provide patient-centered team-based care with excellence in quality, services, and access to all despite any barriers, stigma, socioeconomic or health disparity. 9 9 101 9 0 824490 1542413 18512907 26537197 0 0 7500 3500 19344897 28083110 0 0 0 0 5404825 7555096 0 0 0 13117258 19134457 18522083 26689553 822814 1393557 10345977 10502409 7723925 6486800 2622052 4015609 To provide patient-centered team-based care with excellence in quality, services, and access to all despite any barriers, stigma, socioeconomic or health disparity. false false 19395322 20605956 340B PRESCRIPTION DRUG PROGRAM - AS A RYAN WHITE GRANT-FUNDED ENTITY, WE PROVIDE MEDICAL CARE SERVICES AND TREATMENT SUPPORT AT LITTLE TO NO COST TO UNDERSERVED, LOW-INCOME HIV POSITIVE INDIVIDUALS AND THEIR CAREGIVERS. ELIGIBLE 340B PRESCRIPTIONS ARE DISPENSED AT CONTRACTED PHARMACIES AND THE COST SAVINGS GENERATED BECOME OUR PROGRAM INCOME. THESE FUNDS ARE USED TO GENERATE MORE SERVICES AND ALLOW THE PROGRAM TO CONTINUE TO SERVE THE UNDERSERVED COMMUNITY. 5250404 5923741 OUTPATIENT AMBULATORY MEDICAL CARE SERVICES - WE PROVIDE MEDICAL CARE AND TREATMENT TO PATIENTS. WE PROVIDE PRIMARY CARE, HIV SPECIALTY CARE, ADDICTION AND SUBSTANCE USE DISORDERS, CHRONIC CARE MANAGEMENT, REMOTE PATIENT MONITORING AND MORE. THESE SERVICES ARE BILLED TO THIRD PARTY INSURANCE COMPANIES, GRANT-FUNDED (IF APPROPRIATED), SELF-PAY PATIENTS RESPONSIBILITY OR THROUGH OUR SLIDING SCALE DISCOUNT PROGRAM. HOWEVER, A MAJORITY OF THE FUNDS FOR MEDICAL CARE COMES FROM THIRD PARTY INSURANCE BILLING. 851249 7500 Grant Funded Programs - PREP and SAMHSA 25496975 true true false false false false false false false false true false false true true true true false false false false false false false false false false false false true false false false false false false false false false false false false false false false false false false false false true 7 0 true 101 true false false false false false false false false false false false false X 9 9 false false false false true true true true true false false false false true true true true false true true false false NC X Mohamed Elgohary 7045501995 6010 E WT Harris Blvd Charlotte NC 28215 Daryl Hollnagel Chairman 2.0 X X 0 0 0 Marshall Varner Secretary 2.0 X X 0 0 0 Thomas Holliday Treasurer 2.0 X X 0 0 0 Chandra McCloud Board Member 2.0 X 0 0 0 Demond Richardson Board Member 2.0 X 0 0 0 Jaila Dickenson Board Member 2.0 X 0 0 0 Jeanneth Vasquez Board Member 2.0 X 0 0 0 Keith Yon Board Member 2.0 X 0 0 0 Swat Kabisapathy Board Member 2.0 X 0 0 0 Mohamed Elgohary Chief Financial Officer 40.0 X 134140 0 10339 Olivia Bentley Chief Executive Officer 40.0 X 184251 0 17701 Richard Wynn Chief Medical Officer 40.0 X 435650 0 31888 Zachary Richardson Chief Operations Officer 40.0 X 105437 0 2000 Heather Manos Medical Director of Addiction Medicine 40.0 X 240677 0 14065 Jerry Saunders Medical Director of Pediatrics 40.0 X 202250 0 11865 Chad Ellis PA-C 40.0 X 128402 0 8864 Clarence Ellis MD 40.0 X 267915 0 5815 Jason Hardin Medical Director of HIV/NP 40.0 X 138883 0 11189 Karlton Pettis MD 40.0 X 275466 0 10900 Mandy Occhipinti Director of Quality 40.0 X 142661 0 11935 2255732 0 136561 13 false true false Avant Management LLC 9835 Monroe Rd Charlotte NC 28270 Management Services 234541 1 1299890 242523 1542413 Pharmacy Program 621990 20605956 20605956 Patient Services 621400 5923741 5923741 Medical Research 541700 7500 7500 0 0 0 0 26537197 0 0 0 0 0 Miscellaneous Revenue 900099 3500 3500 0 0 0 0 3500 28083110 26537197 0 3500 1390262 1251236 139026 5197159 4743317 453842 145964 132827 13137 360175 327759 32416 461536 419998 41538 20879 19000 1879 982387 893972 88415 0 49012 44601 4411 371293 337876 33417 461333 419813 41520 989664 900595 89069 14480 13177 1303 57375 52211 5164 263769 240031 23738 88726 80741 7985 Drug Costs 13438675 13438675 Medical Supplies 1713750 1559512 154238 Bridges to Access 346438 315259 31179 Lab Services 311220 283210 28010 25456 23165 2291 0 26689553 25496975 1192578 0 886861 985501 171281 212364 1524867 2548666 0 0 285859 277169 7279 7279 1153754 521662 756032 632092 0 0 1238590 1113715 5475208 4725623 10345977 10502409 1339940 1104419 0 1000000 793966 5383985 4588415 7723925 6486800 X 2622052 4015609 2622052 4015609 10345977 10502409 1393557 0 X false true true false X 603068 592581 565350 824490 1542413 4127902 0 0 603068 592581 565350 824490 1542413 4127902 0 4127902 0 0 0 0 0 7500 3500 11000 4138902 0 0.99734 0.99737 X Schedule A, Part II, Line 10 Other Income DESCRIPTION - MISCELLANEOUS, COLUMN A - 0.0, COLUMN B - 0.0, COLUMN C - 0.0, COLUMN D - 7500.0, COLUMN E - 3500.0, COLUMN F - 11000.0; RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1153754 521662 632092 632092 Other Assets Right of Use Asset 4725623 4725623 Federal Income Taxes Lease Liability 4588415 4588415 X 28083110 0 0 28083110 0 0 28083110 26689553 0 0 26689553 0 0 26689553 Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnote The Group is exempt from income taxes under Section 501(c)(3) of the Internal Revenue Code. Accordingly, no provision for Federal or state income taxes has been made in the accompanying financial statements. The Group is not classified as a private foundation. The Group has implemented the accounting requirements associated with uncertainty in income taxes using the provisions of Financial Accounting Standards Board ("FASB") ASC 740, Income Taxes. Using that guidance, tax positions initially need to be recognized in the financial statements when it is more-likely-than-not the positions will be sustained upon examination by the tax authorities. It also provides guidance for derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As of December 31, 2024 and 2023, the Group had no uncertain tax positions that qualify for either recognition or disclosure in the financial statements and recognized no such interest or penalties during the years ended December 31, 2024 and 2023. X X X false false false false false false false false false Olivia Bentley Chief Executive Officer 178751 0 5500 0 0 0 8270 0 9431 0 201952 0 0 0 Richard Wynn Chief Medical Officer 435650 0 0 0 0 0 22772 0 9116 0 467538 0 0 0 Heather Manos Medical Director of Addiction Medicine 240677 0 0 0 0 0 7776 0 6289 0 254742 0 0 0 Jerry Saunders Medical Director of Pediatrics 202250 0 0 0 0 0 4246 0 7619 0 214115 0 0 0 Mandy Occhipinti Director of Quality 137161 0 5500 0 0 0 5646 0 6289 0 154596 0 0 0 Clarence Ellis MD 266665 0 1250 0 0 0 5500 0 315 0 273730 0 0 0 Jason Hardin Medical Director of HIV/NP 133383 0 5500 0 0 0 4900 0 6289 0 150072 0 0 0 Karlton Pettis MD 274216 0 1250 0 0 0 4531 0 6369 0 286366 0 0 0 Form 990, Part VI, Line 11b Review of form 990 by governing body The organization's form 990 is reviewed by the organization's director of finance prior to filing. Form 990, Part VI, Line 12c Conflict of interest policy Board members must review the conflict of interest policy every two years. Board members are responsible for identifying potential conflicts as they arise and refrain from voting on impacted matters. Form 990, Part VI, Line 15a Process to establish compensation of top management official The board of directors establishes executive compensation utilizing data from comparable organizations. Form 990, Part VI, Line 15b Process to establish compensation of other employees The board of directors establishes executive compensation utilizing data from comparable organizations. Form 990, Part VI, Line 19 Required documents available to the public The organization's governing documents are available to the public upon request.